Scott Shandler

Scott Shandler, Ph.D., MBA, is co-founder of Longevity Biotech. Previously, he was a venture capitalist at BioAdvance, supporting therapeutics, diagnostics, and biomarker investments, and contributed to PolyMedix’s Series A fundraising. His experience includes roles at Accenture, Merck Research Labs, and Inventa. Scott holds a Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania, an MBA from The Wharton School, a Certificate in Bioinformatics from Stanford, and a B.A. in Computer Science from Brandeis University. He is an inventor on multiple patents, has published in leading journals, and served as Principal Investigator on federal and private grants.